国家神经系统疾病临床医学研究中心

China National Clinical Research Center for Neurological Diseases

中文版 English

邮箱入口会议预约系统

十周年重要论文汇编

CHANCE试验

CHANCE基因研究

PRINCE试验

CHANCE-2试验

INSPIRES试验

TRACE-2试验

ANGEL-ASPECT试验

CATIS-2试验

ARAIS试验

Golden-Bridge试验

主持制定的国际指南

参与的国际多中心临床试验

脑健康学术新方向及其他

主页 > 十周年重要论文汇编 > CHANCE-2试验

CHANCE-2试验

Ticagrelor versus Clopidogrel in Loss-of-Function Carriers with Stroke or TIA

Date：2024.03.20
Ticagrelor-Aspirin Versus Clopidogrel-Aspirin Among Loss-of-Function Carriers With Minor Stroke or Transient Ischemic Attack in Relation to Renal Function: A Post Hoc Analysis of the CHANCE-2 Trial

Date：2024.03.20
Time Course for Benefit and Risk With Ticagrelor and Aspirin in Individuals With Acute Ischemic Stroke or Transient Ischemic Attack Who Carry Loss-of-Function Alleles A Secondary Analysis of the CHANCE-2 Randomized Clinical Trial

Date：2024.03.20
Bleeding Risk of Dual Antiplatelet Therapy after Minor Stroke or Transient Ischemic

Date：2024.03.20
Effect of Hypertension on Efficacy and Safety o Ticagrelor-Aspirin Versus Clopidogrel- Aspirin in Minor Stroke or Transient Ischemic Attack

Date：2024.03.20
Impact of body mass index on efficacy and safety of ticagrelor versus clopidogrel in patients with minor stroke or transient ischemic attack

Date：2024.03.20
Association of CYP2C19 Loss-of-Function Metabolizer Status With Stroke Risk Among Chinese Patients Treated With Ticagrelor-Aspirin vs Clopidogrel-Aspirin: A Prespecified Secondary Analysis of a Random Clinical Trial

Date：2024.03.20
Genotype-Guided Dual Antiplatelet Use for Transient Ischemic Attack and Minor Stroke by Imaging Status: Subgroup Analysis of the CHANCE-2 Trial

Date：2024.03.20
Genotype-Guided Dual Antiplatelet Therapy in Minor Stroke or Transient Ischemic Attack With a Single Small Subcortical Infarction

Date：2024.03.20
Ticagrelor Aspirin vs Clopidogrel Aspirin in CYP2C19 Loss-of-Function Carriers With Minor Stroke or TIA Stratified by Risk Profile

Date：2024.03.20

首页
1
2
下一页
末页
共2页13条